Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

Hair loss can cause stress and needs different treatments based on its type.

The p.P25L mutation in the KRT5 gene causes a rare skin condition that worsens over time and may lead to hair loss starting in young adulthood.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Fractional CO2 laser treatment could be effective for alopecia areata.

The document concludes that treatment improved skin lesions but not scalp hair loss in two patients with Graham-Little-Piccardi-Lassueur syndrome.

Hair growth treatment results vary because each patient's platelets release different levels of growth factors.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

PRP therapy is a safe and effective treatment for hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

A baby boy had two types of temporary hair loss at birth, which might be two forms of newborn hair loss combined.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Hydroxychloroquine can help treat certain types of hair loss.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.